Skip to content

Illumina ILMN Helix — Revenue

Discontinued — last reported Q4 '21

Similar metrics at other companies

TD SYNNEX logo
SNXHyve Solutions — Revenue
$2.15B+24.2%
Ionis Pharmaceuticals logo
IONSRevenue
$203.33M-10.3%
CVS Health logo
CVSHealth Services — Revenue
$48.24B+11.0%
Leidos Holdings logo
LDOSHealth — Revenue
$1.19B0.0%
Match Group logo
MTCHHinge — Revenue
$194.5M+27.8%
STERIS logo
STEHealthcare — Revenue
$1.14B+7.5%

Other financials

Income statement

See full
Revenue$1.1B+4.8%
Gross profit$721.0M+5.6%
Operating income$209.0M+27.4%
Net income$134.0M+2.3%
EPS (diluted)$0.87+6.1%

Balance sheet

See full
Cash & equivalents$1.1B-2.2%
Total debt$2.0B-3.0%
Total equity$2.7B+13.0%
Total assets$6.6B+6.1%

Cash flow

See full
Operating cash flow$289.0M+20.4%
CapEx$38.0M+18.8%
Free cash flow$251.0M+20.7%

Valuation

See full
Market cap$24.5B+50.0%
Enterprise value$25.46B+46.0%
P/E28.7×
P/S5.6×+1.8×

Profitability

See full
Gross margin66.2%-0.1pp
Operating margin19.4%
Net margin19.4%+12.7pp
FCF margin22.2%+2.0pp

Returns & leverage

See full
Return on equity33.8%+23.9pp
Debt / equity0.8×-0.1×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Illumina’s 10-K, filed February 18, 2022, on SEC EDGAR. View the filing →

Ask your AI about Illumina's helix — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's helix — revenue?
Illumina (ILMN) reported helix — revenue of $0 in Q4 2021.